VEA
GOSS icon

Virtus ETF Advisers’s Gossamer Bio GOSS Stock Holding History

Virtus ETF Advisers’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,496
Closed -$210K – 463
2022
Q3 		$210K Buy
17,496
+126
+0.7% +$1.56K 0.08% 315
2022
Q2 		$145K Buy
17,370
+2,331
+15% +$18.1K 0.05% 323
2022
Q1 		$131K Sell
15,039
-893
-6% -$8.61K 0.06% 248
2021
Q4 		$180K Sell
15,932
-8,178
-34% -$97.1K 0.07% 247
2021
Q3 		$303K Sell
24,110
-1,251
-5% -$11.5K 0.13% 199
2021
Q2 		$206K Sell
25,361
-3,102
-11% -$26.9K 0.08% 326
2021
Q1 		$263K Buy
28,463
+500
+2% +$5.04K 0.11% 275
2020
Q4 		$270K Buy
27,963
+2,834
+11% +$27.9K 0.11% 275
2020
Q3 		$312K Sell
25,129
-3,425
-12% -$45.4K 0.16% 212
2020
Q2 		$371K Buy
28,554
+14,388
+102% +$181K 0.18% 234
2020
Q1 		$144K Sell
14,166
-2,079
-13% -$27.1K 0.06% 288
2019
Q4 		$254K Buy
16,245
+3,772
+30% +$76K 0.04% 288
2019
Q3 		$209K Sell
12,473
-695
-5% -$13.8K 0.04% 241
2019
Q2 		$292K Buy
+13,168
New +$252K 0.06% 226

Other funds holding GOSS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Virtus ETF Advisers's GOSS Position: Q4 2022 in Review

Virtus ETF Advisers sold out of Gossamer Bio (GOSS) in Q4 2022, closing a stake of 17,496 shares — an estimated $210K sold.

Virtus ETF Advisers first reported a position in GOSS in Q2 2019 and held it in 14 quarters. The position peaked at $371K in Q2 2020. 120 funds tracked by Wall St. Rank hold GOSS as of Q4 2022.

  • Virtus ETF Advisers reported no remaining Gossamer Bio position as of Q4 2022 after selling out during the quarter.
  • Virtus ETF Advisers sold 17,496 Gossamer Bio shares in Q4 2022, an estimated $210K.
  • Virtus ETF Advisers first reported a position in Gossamer Bio in Q2 2019 and held it in 14 quarters.
  • Virtus ETF Advisers's Gossamer Bio position peaked at $371K in Q2 2020.
  • 120 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2022.

Based on Virtus ETF Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.